Aug 27, 2021

Echuca aged care home in lockdown after staff member tests positive

Echuca aged care home in lockdown after staff member tests positive

An aged care home in northern Victoria has been locked down after a vaccinated staff member tested positive for coronavirus.

Authorities believe that a staff member working at the Wharparilla Lodge aged care facility in Echuca attended the private facility for a short period on August 20.

COVID-19 testing commander Jeroen Weimar told reporters that the staff member had been previously vaccinated for COVID-19, despite testing positive. Mr Weimar also said that the staff member caught the virus from her partner, who had been previously connected to a cluster in Shepparton.

“There is a full response going on with the aged care response team and we are continuing to support that closely, but my thanks to their team there at that facility and everyone there to support that aged care facility,” Mr Weimar said.

“We have about 40 staff who are currently on furlough and being backed in by other agency staff to ensure we can continue to function safely.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

New technologies help aged care providers deliver holistic care to residents

Andres Rehbein, who is a self-confessed IT “nerd”, is using technology to improve efficiency and quality of care at Queensland-based aged care provider, PresCare. At Akolade’s Technology in Aged Care Forum, held on 26-28 June, Andres Rehbein spoke of the ways he and his team at PresCare have used technology to improve efficiency in their... Read More

Older pets: The perfect gift for older animal lovers

Do you have older relatives who are battling loneliness? Stumped on what to get them this holiday season? Consider the best gift of all – love and companionship from an older furry friend! Read More

Devil is in detail in government response to psychotropic misuse

  Restricting the use of one type of psychotropic is likely to mean other, less well studied drugs will be prescribed in their place, says a leading dementia medication expert. On Monday, the government announced a $537m funding package to address concerns raised in the Royal Commission into Aged Care Quality and Safety’s interim report.... Read More
Advertisement